We're looking forward to attending this year's Schizophrenia International Society Conference (SIRS). Will we see you there?
As part of the conference, Dr Kiri Granger and Dr Jack Cotter will be joined by leading experts from Autifony Therapeutics, Karuna Pharmaceuticals, and Washington University in St Louis for a symposium entitled: Addressing Methodological Challenges in CIAS to Enhance Clinical Trial Success. Join the event 13 April, 10 a.m. - 12 p.m. in Regency R.
Chief Scientific Officer, Dr Jenny Barnett, will also be presenting on: Latent Inhibition as a Stratification Tool for Schizophrenia Drug Development. Catch Dr Barnett 13 April, 6.15 p.m. in Orlando Ballroom N.
During the conference, the Cambridge Cognition science team, along with Mark Levine (Business Development Director, East Coast), will also be available to answer any questions you may have around optimising your schizophrenia trials.
Please contact us for more information on our research or to arrange a time to meet the team in Orlando.